More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

Experts believe the study highlights the need for more targeted health evaluations beyond BMI, especially as belly fat ...

In this Phase 2a clinical trial (NCT06256523), 36 adults with T2DM who had inadequate glycemic control through diet and exercise and/or irregular use of antidiabetic medications, were randomized to ...

A daily handful of almonds could significantly boost heart health and gut function in people with metabolic syndrome, new ...